Bioharvest Sciences OTC Stock Top Insiders

CNVCF Stock  USD 6.15  0.03  0.49%   
Bioharvest Sciences employs about 6 people. The company is managed by 6 executives with a total tenure of roughly 14 years, averaging almost 2.0 years of service per executive, having 1.0 employees per reported executive. Examination of Bioharvest Sciences' management performance can provide insight into the company performance.
Zaki Rakib  Insider
CoFounder Chairman
BCom BComm  Insider
Chief Officer
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bioharvest Sciences. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

Bioharvest Sciences Management Team Effectiveness

The company has return on total asset (ROA) of (0.5264) % which means that it has lost $0.5264 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (63.6438) %, meaning that it generated substantial loss on money invested by shareholders. Bioharvest Sciences' management efficiency ratios could be used to measure how well Bioharvest Sciences manages its routine affairs as well as how well it operates its assets and liabilities.

Bioharvest Sciences Workforce Comparison

Bioharvest Sciences is number one stock in number of employees category among its peers. The total workforce of Drug Manufacturers—Specialty & Generic industry is currently estimated at about 1,642. Bioharvest Sciences adds roughly 6.0 in number of employees claiming only tiny portion of equities under Drug Manufacturers—Specialty & Generic industry.
The company has Profit Margin (PM) of (2.69) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (2.45) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $2.45.

Bioharvest Sciences Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Bioharvest Sciences Price Series Summation is a cross summation of Bioharvest Sciences price series and its benchmark/peer.

Bioharvest Sciences Notable Stakeholders

A Bioharvest Sciences stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Bioharvest Sciences often face trade-offs trying to please all of them. Bioharvest Sciences' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Bioharvest Sciences' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Zaki RakibCoFounder ChairmanProfile
BCom BCommChief OfficerProfile
Brian CornblattChief OfficerProfile
David RyanS RelationsProfile
Yochi HagayCTO CoFounderProfile
Ilan SobelChief OfficerProfile

About Bioharvest Sciences Management Performance

The success or failure of an entity such as Bioharvest Sciences often depends on how effective the management is. Bioharvest Sciences management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Bioharvest management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Bioharvest management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
BioHarvest Sciences Inc., together with its subsidiaries, offers nutraceutical super fruits and cannabis verticals in Israel and internationally. The company designs, develops, manufactures, and markets Vinia, a red grape powder nutraceutical product and medical cannabis. Canna-V-Cell Sciences is traded on OTC Exchange in the United States.
The data published in Bioharvest Sciences' official financial statements typically reflect Bioharvest Sciences' business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Bioharvest Sciences' quantitative information. For example, before you start analyzing numbers published by Bioharvest accountants, it's essential to understand Bioharvest Sciences' liquidity, profitability, and earnings quality within the context of the Healthcare space in which it operates.

Bioharvest Sciences Workforce Analysis

Traditionally, organizations such as Bioharvest Sciences use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Bioharvest Sciences within its industry.

Bioharvest Sciences Manpower Efficiency

Return on Bioharvest Sciences Manpower

Revenue Per Employee350.3K
Revenue Per Executive350.3K
Net Loss Per Employee1.6M
Net Loss Per Executive1.6M

Complementary Tools for Bioharvest OTC Stock analysis

When running Bioharvest Sciences' price analysis, check to measure Bioharvest Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioharvest Sciences is operating at the current time. Most of Bioharvest Sciences' value examination focuses on studying past and present price action to predict the probability of Bioharvest Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioharvest Sciences' price. Additionally, you may evaluate how the addition of Bioharvest Sciences to your portfolios can decrease your overall portfolio volatility.
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation